Antonio Casado Herráez-rekin lankidetzan egindako argitalpenak (7)

2010

  1. Advanced ovarian cancer: Phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel

    Journal of the National Cancer Institute, Vol. 102, Núm. 20, pp. 1547-1556

2005

  1. 2004 consensus statements on the management of ovarian cancer: Final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)

    Annals of Oncology

  2. 3rd International Ovarian Cancer Consensus Conference: Outstanding issues for future consideration

    Annals of Oncology

  3. Integration of new or experimental treatment options and new approaches to clinical trials

    Annals of Oncology

  4. Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: A GEICO (Grupo Español de Investigación en Cáncer de Ovario) study

    Annals of Oncology, Vol. 16, Núm. 5, pp. 749-755

1997

  1. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: A phase II trial of the Spanish group for ovarian cancer

    Seminars in Oncology

1994

  1. Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy

    Annals of Oncology, Vol. 5, Núm. 9, pp. 854-857